As the Senior Director of Integrated Solutions Marketing for the BioContinuum Platform at MilliporeSigma, Michael Felo is at the forefront of advancing bioprocessing technologies that are crucial for the development of innovative therapeutics. With over 20 years of experience in the biotechnology and pharmaceutical industries,...
As the Senior Director of Integrated Solutions Marketing for the BioContinuum Platform at MilliporeSigma, Michael Felo is at the forefront of advancing bioprocessing technologies that are crucial for the development of innovative therapeutics. With over 20 years of experience in the biotechnology and pharmaceutical industries, Michael combines his extensive knowledge in downstream purification with a deep understanding of market dynamics to lead a talented team of product managers and industry experts. His current role focuses on delivering next-generation integrated systems, raw materials, and purification technologies that enhance the efficiency and effectiveness of biologic therapy production.
One of Michael's key projects involves the development of advanced filtration and chromatography technologies that leverage MilliporeSigma's core competencies in membranes and chemistry. By pushing the boundaries of these technologies, he is enabling innovators to purify complex biologic therapies more quickly, robustly, and cost-effectively. His strategic vision is not only about improving product performance but also about ensuring compliance with FDA regulations and industry standards, which is critical in the highly regulated life sciences sector.
Michael's leadership in marketing and product management has been instrumental in driving growth and fostering collaboration across various teams. His expertise in protein purification, vaccines, and disposable technologies positions him as a thought leader in the industry. By focusing on integrated solutions that address the evolving needs of biopharmaceutical manufacturers, Michael is committed to supporting the development of life-saving and life-enhancing therapeutics that can transform patient care.
